Assessing Mondelez International (MDLZ) Valuation After ESG Report, Cell-Cultured Cocoa Push And Shareholder Pressure

Mondelez International (MDLZ) is in focus after releasing its 2025 sustainability progress report and highlighting work with Celleste Bio on cell cultured cocoa butter, alongside fresh shareholder pressure on plastics packaging and board leadership.

See our latest analysis for Mondelez International.

At a share price of US$57.07, Mondelez has seen a 6.37% year to date share price return, while its 1 year total shareholder return of 12.40% and 3 year total shareholder return of 12.63% indicate weaker long term outcomes despite recent ESG and product announcements.

If this mix of sustainability, cocoa technology, and marketing pushes you to look beyond a single name, it could be a good moment to broaden your search with 19 top founder-led companies

With MDLZ trading at US$57.07, sitting at a discount to some analyst targets yet carrying a weaker 1 year and 3 year total return, you have to ask: is there real value here, or is future growth already priced in?

Most Popular Narrative: 13.6% Undervalued

With Mondelez trading at $57.07 against a narrative fair value of $66.08, the current share price sits meaningfully below that central estimate, setting up a clear valuation debate for anyone following the stock.

Mondelez International is executing a robust pricing strategy in response to high cocoa costs, which is expected to improve revenue as pricing takes effect globally, especially in markets like Europe and emerging markets. The company is implementing a strategic growth agenda that includes reinvesting in brands, expanding distribution, and strengthening market presence, which should positively impact revenue growth and market share.

Read the complete narrative.

Want to understand why this valuation still looks supportive even after lower growth and margin assumptions, and what earnings profile has been baked into that 7% discount rate? The narrative leans on a detailed path for revenue, profitability and the future earnings multiple applied to Mondelez, and the tension between tempered expectations and a higher projected profit base is where the story gets interesting.

Result: Fair Value of $66.08 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, softer volumes in North America and ongoing pressure from high cocoa costs could still unsettle margins and challenge the earnings recovery story that investors are watching.

Find out about the key risks to this Mondelez International narrative.

Another Angle On The Valuation

The narrative fair value of US$66.08 suggests Mondelez is undervalued, but the current P/E of 29.9x tells a more cautious story. It is higher than the US Food industry at 21.3x and above a fair ratio of 26.6x, even if it sits below peer levels at 43.6x. That gap leaves you weighing upside potential against the risk that the market shifts closer to the lower fair ratio instead of the richer peer group. Which side do you think it drifts toward?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

If this mix of optimism and caution around Mondelez leaves you unsure, it may be helpful to review the details yourself and form your own view, starting with its 2 key rewards and 3 important warning signs

Looking for more investment ideas?

If Mondelez has sharpened your focus, do not stop here. Use carefully built stock lists to spot fresh ideas that fit your goals and risk comfort.

• Target value by scanning companies that combine quality fundamentals with attractive pricing using the 58 high quality undervalued stocks.
• Prioritise resilience by searching for companies with stronger finances through the solid balance sheet and fundamentals stocks screener (42 results).
• Spot potential early movers by reviewing a screener containing 23 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com